tiprankstipranks

Stengone Carmine N. Insider Profile

4 Followers
Stengone Carmine N., CEO & President, Director at Contineum Therapeutics, Inc. Class A, holds 17.22K shares in Contineum Therapeutics, Inc. Class A (Ticker: CTNM), holds 1.25K shares in Kiora Pharmaceuticals (Ticker: KPRX).
tipranks
Stengone Carmine N.

Stengone Carmine N.
Contineum Therapeutics, Inc. Class A (CTNM)
CEO & President, Director

Not Ranked
Stengone Carmine N. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$258K
98.72%
1.28%
A breakdown of Stengone Carmine N.'s holdings

Insider Roles

Contineum Therapeutics, Inc. Class A
(CTNM)
CEO & President, Director
Kiora Pharmaceuticals
(KPRX)
Director
Roles that Stengone Carmine N. holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Stengone Carmine N.

Stengone Carmine N.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Contineum Therapeutics, Inc. Class A
Sep 08, 2026
CEO & President, Director
Uninformative Buy
2.52K
$255.16K
Kiora Pharmaceuticals
Sep 12, 2024
Director
Informative Buy
4.60K
$3.31K
List of latest transactions for each holding click on a transaction to see Stengone Carmine N.'s performance on stock

Stengone Carmine N. insider profile FAQ

What is the percentage of profitable transactions made by Stengone Carmine N.?
The percentage of profitable transactions made by Stengone Carmine N. is ―.
    What is the average return per transaction made by Stengone Carmine N.?
    The average return per transaction made by Stengone Carmine N. is ―.
      What stocks does Stengone Carmine N. hold?
      Stengone Carmine N. holds: CTNM, KPRX stocks.
        What was Stengone Carmine N.’s latest transaction?
        Stengone Carmine N. latest transaction was an Uninformative Buy of $2.52K.
          What was Stengone Carmine N.'s most profitable transaction?
          Stengone Carmine N.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Stengone Carmine N.'s role in Contineum Therapeutics, Inc. Class A?
            Stengone Carmine N.'s role in Contineum Therapeutics, Inc. Class A is CEO & President, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.